3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
20
Sarcoma
7
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Adenoma, Pleomorphic
1
Recurrence
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Oropharyngeal Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Interventions
Exercise
24
Metformin
19
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
7
Surveys and Questionnaires
6
semaglutide
5
Liraglutide
5
Exenatide
5
Early Intervention, Educational
5
Diet, Mediterranean
5
Caloric Restriction
5
Blood Specimen Collection
5
Educational Status
4
Bariatric Surgery
4
Vitamin D
3
Sugars
3
Standard of Care
3
Naltrexone
3
Letrozole
3
Docosahexaenoic Acids
3
Dexamethasone
3
Bupropion
3
exemestane
2
bupropion hydrochloride, naltrexone hydrochoride drug combination
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Obesity
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled